In summary, our present work provides the first evidence that VRK1 plays an essential role in the initiation and progression of ESCC as well as the induction of CDDP resistance via c-Jun-mediated c-MYC activation. The gene discussed is MYC; the disease is esophageal squamous cell carcinoma.